JCBFM, May 2008.

 

You can find all the JCBFM summaries in web format at:

 

http://sullydog.com/sullysites/jclub/

 

All articles are listed. My relevance assessment is entirely implicit and is designated with regard to work we are doing or contemplating RIGHT NOW. The relevance of an article might change in the future. Those papers with relevance rated VERY LOW do not get a Sullysummary.

 

-------------------------------------------------------

 

*1. Review Article: Acute neurodegeneration and the inflammasome: central processor for danger signals and the inflammatory response? George Trendelenburg

 

Sullysummary: I think you should check this out if you have the chance, if only to get up to speed on a buzzword you're likely to be hearing a lot about. When they talk about the inflammasome, they're talking about something very similar to the apoptosome, only a LOT more elaborate. Basically, here's the story: after injury, damage-associated molecular patterns (DAMPs) activate Toll-like receptors (TLRs) that promote the assemply of an inflammasome complex. These DAMPs include hyaluronin, HSPs, IFN-a, fibronectin, and cardiolipin (!). THe inflammasome that is activated by these DAMPs via the TLRs incorporates caspace-1, and its activation is essential for hte caspase-mediated processing of interleukin-1 and IL-18. Activation of the inflammasome is associated with both cell death and neuroprotection, depending on how things balance on the knife edge. Of course, I'm vastly oversimplifying things, so scan the article for yourself. The immediate relevance for us is moderate, but it may end up having high relevance for Karin's myocardial model and our nascent focal ischemia model.

 

Relevance: Medium-HIGH

Link (PDF): http://www.nature.com/jcbfm/journal/v28/n5/pdf/9600609a.pdf

 

-------------------------------------------------------

 

*2. Brief Communication: Verification of enhancement of the CSF space, not parenchyma, in acute stroke patients with early blood–brain barrier disruption. Henning, et al.

 

Relevance: VERY LOW.

Link (PDF): http://www.nature.com/jcbfm/journal/v28/n5/pdf/9600598a.pdf

 

-------------------------------------------------------

 

*3. Brief Communication Optimal definition for PWI/DWI mismatch in acute ischemic stroke patients. Kakuda et al.

 

Sullysummary: This is a clinical MRI study. It identified a ration of perfusion-weighted imaging to diffusion-weighted imagint that seemed to identify which patients would do better with t-PA. May have some relevance for Anthony and Yours Truly as we go forward into rat MRI Land with our focal ischemia model in our bid to capture some Genentech dollars.

 

Relevance: Medium

Link (PDF): http://www.nature.com/jcbfm/journal/v28/n5/pdf/9600604a.pdf

 

-------------------------------------------------------

 

*4. Transient focal cerebral ischemia induces a dramatic activation of small ubiquitin-like modifier conjugation. Yang et al.

 

Sullysummary: Sumoylation, a post-translational modification by SUMO (small ubiquitin-like modifer) proteins, is massively activated after transient forebrain ischemia. Similar to ubiquination...but different. The authors don't actually talk about the nitty-gritty of sumoylation, so I did some digging. In contrast to ubiquitin, SUMO is not used to tag proteins for degradation. Mature SUMO is produced when the last four amino acids of the C-terminus have been cleaved off. SUMO modification of proteins has many functions. Among the most frequent and best studied are protein stability, nuclear-cytosolic transport, transcriptional regulation (mostly transcriptional repression). As opposed to poly-ubiquitin modification which targets proteins for degradation, SUMOylation increases a protein's lifetime. It can also change a protein's location in the cell.The response of SUMO 2/3 proteins in this study really does warrant the word "massive." The authors, in the discussion, mention the role of sumoylation in hibernating rodents (squirrels, sleeping republicans), which gets me thinking. Sumoylation is supposedly a protective response. Wonder what happens in hypothermia? Might be worth a look. Anthony? 

 

Relevance: Medium. 

Link (PDF): http://www.nature.com/jcbfm/journal/v28/n5/pdf/9600601a.pdf

 

-------------------------------------------------------

 

*5. Autophagy after experimental intracerebral hemorrhage. He et al.

 

Sullysummary: Ah, the new buzzword: ah-TAH-fuh-jee. This study was focused on ICH, using a very crude but, I must say, relevant model of intracerebral hemorrhage (take blood from rat, inject blood into brain tissue). The paper is of interest primarily for the assays the authors used: conversion of microtubule-associated protein light chain-3 (LC3) from LC3-I to LC3-II, a marker of the autophagosome, and expression of cathepsin D, a lysosomal biomarker. The authors also used EM to look at typical ultrastructural changes. In a related experiment, they demonstrate that it's not blood per se, but iron that appears to be the culprit. Worth a look.

 

Relevance: Medium 

Link (PDF): http://www.nature.com/jcbfm/journal/v28/n5/pdf/9600578a.pdf

 

-------------------------------------------------------

 

*6. Gamma-aminobutyric acid modulates local brain oxygen consumption and blood flow in rat cerebellar cortex. Caesar et al.

 

Relevance: VERY LOW.

Link (PDF): http://www.nature.com/jcbfm/journal/v28/n5/pdf/9600581a.pdf

 

-------------------------------------------------------

 

*7. Cerebral blood flow autoregulation in experimental liver failure. Dethloff et al.

 

Relevance: VERY LOW.

Link (PDF): http://www.nature.com/jcbfm/journal/v28/n5/pdf/9600589a.pdf

 

-------------------------------------------------------

 

*8. Inhibition of Ih in striatal cholinergic interneurons early after transient forebrain ischemia. Deng et al.

 

Relevance: VERY LOW.  

Link (PDF): http://www.nature.com/jcbfm/journal/v28/n5/pdf/9600582a.pdf

 

-------------------------------------------------------

 

 

*9. Cerebral blood volume quantification in a C6 tumor model using gadolinium per (3,6-anhydro) a-cyclodextrin as a new magnetic resonance imaging preclinical contrast agent. Lahrech, et al.

 

Relevance: VERY LOW. 

Link (PDF): http://www.nature.com/jcbfm/journal/v28/n5/pdf/9600602a.pdf

 

-------------------------------------------------------

 

*10. Mannose binding lectin gene deficiency increases susceptibility to traumatic brain injury in mice. Yager et al.

 

Relevance: VERY LOW. 

Link (PDF): http://www.nature.com/jcbfm/journal/v28/n5/pdf/9600605a.pdf

-------------------------------------------------------

 

*12. Toll-like receptor 9: a new target of ischemic preconditioning in the brain. Stevens et al.

 

Sullysummary: This is one you might want to look at after reading the review on the inflammasome in this same issue. In accordance with Krause's law, TLR9 ligand reduced infarct volume in an MCAO model, and implicate this receptor system in TNF-mediated preconditioning-neuroprotection.

 

Relevance: Low.

Link (PDF): http://www.nature.com/jcbfm/journal/v28/n5/pdf/9600606a.pdf

-------------------------------------------------------

 

*13. C3a receptor modulation of granulocyte infiltration after murine focal cerebral ischemia is reperfusion dependent. Ducruet et al.

 

Relevance: VERY LOW. 

Link (PDF): http://www.nature.com/jcbfm/journal/v28/n5/pdf/9600608a.pdf

 

-------------------------------------------------------

 

*14. Measurement of striatal and extrastriatal dopamine transporter binding with high-resolution PET and [11C]PE2I: quantitative modeling and test–retest reproducibility. Hirvonen et al.

 

Relevance: VERY LOW. 

Link (PDF): http://www.nature.com/jcbfm/journal/v28/n5/pdf/9600607a.pdf

 

-------------------------------------------------------

 

END SUMMARY.